The host immunologic response to West Nile encephalitis virus

Frontiers in Bioscience

Volumn 14, Issue 8, 2009, Pages 3024-3040

  Diamond, Michael S ^a   Mehlhop, Erin ^a   Oliphant, Theodore ^a   Samuel, Melanie A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody; Flavivirus; Immunology; Interferon; Pathogenesis; Review; T cells

Indexed keywords

ARBOVIRUS; AVES; EQUIDAE; FLAVIVIRIDAE; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; JAPANESE ENCEPHALITIS VIRUS GROUP; RNA VIRUSES; VERTEBRATA; WEST NILE VIRUS;

ADAPTATION; AGED; ANIMAL; CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; REVIEW; VIROLOGY; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ADAPTATION, PHYSIOLOGICAL; AGED; ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNITY, INNATE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 63849262694     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2735/3432     Document Type: Review

References (224)

1. Hayes, E. B., N. Komar, R. S. Nasci, S. P. Montgomery, D. R. O'Leary & G. L. Campbell: Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis, 11, 1167-73 (2005). (Pubitemid 41045321)
2. Sejvar, J. J., M. B. Haddad, B. C. Tierney, G. L. Campbell, A. A. Marfin, J. A. Van Gerpen, A. Fleischauer, A. A. Leis, D. S. Stokic & L. R. Petersen: Neurologic manifestations and outcome of West Nile virus infection. JAMA, 290, 511-5 (2003). (Pubitemid 37430505)
3. Petersen, L. R., A. A. Marfin & D. J. Gubler: West Nile virus. Jama, 290, 524-8 (2003). (Pubitemid 37430506)
4. Davis, L. E., R. DeBiasi, D. E. Goade, K. Y. Haaland, J. A. Harrington, J. B. Harnar, S. A. Pergam, M. K. King, B. K. DeMasters & K. L. Tyler: West Nile virus neuroinvasive disease. Ann Neurol, 60, 286-300 (2006). (Pubitemid 44520233)
5. Sejvar, J. J., A. V. Bode, A. A. Marfin, G. L. Campbell, J. Pape, B. J. Biggerstaff & L. R. Petersen: West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis, 12, 514-6 (2006).
6. Sejvar, J. J.: The long-term outcomes of human West Nile virus infection. Clin Infect Dis, 44, 1617-24 (2007). (Pubitemid 46871510)
7. Kleinschmidt-DeMasters, B. K., B. A. Marder, M. E. Levi, S. P. Laird, J. T. McNutt, E. J. Escott, G. T. Everson & K. L. Tyler: Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol, 61, 1210-20 (2004). (Pubitemid 39062673)
8. Hubalek, Z. & J. Halouzka: West Nile fever - a reemerging mosquito-borne viral disease in Europe. Emerg Inf Dis, 5, 643-650 (1999). (Pubitemid 29493766)
9. Komar, N. & G. G. Clark: West Nile virus activity in Latin America and the Caribbean. Rev Panam Salud Publica, 19, 112-7 (2006). (Pubitemid 44147364)
10. Brault, A. C., C. Y. Huang, S. A. Langevin, R. M. Kinney, R. A. Bowen, W. N. Ramey, N. A. Panella, E. C. Holmes, A. M. Powers & B. R. Miller: A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet, 39, 1162-1166 (2007). (Pubitemid 47340649)
11. Busch, M. P., S. Caglioti, E. F. Robertson, J. D. McAuley, L. H. Tobler, H. Kamel, J. M. Linnen, V. Shyamala, P. Tomasulo & S. H. Kleinman: Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med, 353, 460-7 (2005). (Pubitemid 41127290)
12. Busch, M. P., D. J. Wright, B. Custer, L. H. Tobler, S. L. Stramer, S. H. Kleinman, H. E. Prince, C. Bianco, G. Foster, L. R. Petersen, G. Nemo & S. A. Glynn: West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis, 12, 395-402 (2006).
13. Chambers, T. J., C. S. Hahn, R. Galler & C. M. Rice: Flavivirus genome organization, expression, and replication. Annu Rev Microbiol, 44, 649-88 (1990).
14. Brinton, M. A.: The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol, 56, 371-402 (2002). (Pubitemid 35217460)
15. Mukhopadhyay, S., R. J. Kuhn & M. G. Rossmann: A structural perspective of the flavivirus life cycle. Nat Rev Microbiol, 3, 13-22 (2005). (Pubitemid 40028466)
16. Lindenbach, B. D. & C. M. Rice: trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol, 71, 9608-17 (1997). (Pubitemid 27492408)
17. Khromykh, A. A., P. L. Sedlak, K. J. Guyatt, R. A. Hall & E. G. Westaway: Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J Virol, 73, 10272-80 (1999).
18. Winkler, G., S. E. Maxwell, C. Ruemmler & V. Stollar: Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology, 171, 302-5 (1989). (Pubitemid 19180804)
19. Macdonald, J., J. Tonry, R. A. Hall, B. Williams, G. Palacios, M. S. Ashok, O. Jabado, D. Clark, R. B. Tesh, T. Briese & W. I. Lipkin: NS1 Protein Secretion during the Acute Phase of West Nile Virus Infection. J Virol, 79, 13924-13933 (2005). (Pubitemid 41552691)
20. Chung, K. M., M. K. Liszewski, G. Nybakken, A. E. Davis, R. R. Townsend, D. H. Fremont, J. P. Atkinson & M. S. Diamond: West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci U S A, 103, 19111-19116 (2006). (Pubitemid 350002836)
21. Liu, W. J., H. B. Chen, X. J. Wang, H. Huang & A. A. Khromykh: Analysis of adaptive mutations in kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol, 78, 12225-12235 (2004). (Pubitemid 39458742)
22. Liu, W. J., X. J. Wang, D. C. Clark, M. Lobigs, R. A. Hall & A. A. Khromykh: A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol, 80, 2396-404 (2006). (Pubitemid 43271545)
23. Liu, W. J., H. B. Chen & A. A. Khromykh: Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. J Virol, 77, 7804-13 (2003). (Pubitemid 36792777)
24. Khromykh, A. A., P. L. Sedlak & E. G. Westaway: cisand trans-acting elements in flavivirus RNA replication. J Virol, 74, 3253-63 (2000). (Pubitemid 30143750)
25. Yusof, R., S. Clum, M. Wetzel, H. M. Murthy & R. Padmanabhan: Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem, 275, 9963-9 (2000). (Pubitemid 30202042)
26. Liu, W. J., X. J. Wang, V. V. Mokhonov, P. Y. Shi, R. Randall & A. A. Khromykh: Inhibition of interferon signaling by the New York 99 strain and kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol, 79, 1934-1942 (2005). (Pubitemid 40459140)
27. Munoz-Jordan, J. L., M. Laurent-Rolle, J. Ashour, L. Martinez-Sobrido, M. Ashok, W. I. Lipkin & A. Garcia- Sastre: Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol, 79, 8004-13 (2005). (Pubitemid 40853504)
28. Guo, J. T., J. Hayashi & C. Seeger: West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol, 79, 1343-50 (2005). (Pubitemid 40459081)
29. Egloff, M. P., D. Benarroch, B. Selisko, J. L. Romette & B. Canard: An RNA cap (nucleoside-2'-O-)- methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. Embo J, 21, 2757-68 (2002). (Pubitemid 34619391)
30. Khromykh, A. A., P. L. Sedlak & E. G. Westaway: trans-Complementation analysis of the flavivirus Kunjin ns5 gene reveals an essential role for translation of its Nterminal half in RNA replication. J Virol, 73, 9247-55 (1999). (Pubitemid 29487080)
31. Best, S. M., K. L. Morris, J. G. Shannon, S. J. Robertson, D. N. Mitzel, G. S. Park, E. Boer, J. B. Wolfinbarger & M. E. Bloom: Inhibition of interferonstimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol, 79, 12828-39 (2005). (Pubitemid 41433202)
32. Lin, R. J., B. L. Chang, H. P. Yu, C. L. Liao & Y. L. Lin: Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol, 80, 5908-5918 (2006).
33. Park, G. S., K. L. Morris, R. G. Hallett, M. E. Bloom & S. M. Best: Identification of Residues Critical for the Interferon Antagonist Function of Langat Virus NS5 Reveals a Role for the RNA-Dependent RNA Polymerase Domain. J Virol, 81, 6936-46 (2007). (Pubitemid 46986630)
34. Chu, J. J. & M. L. Ng: Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. J Biol Chem, 279, 54533-41 (2004). (Pubitemid 40053195)
35. Davis, C. W., H. Y. Nguyen, S. L. Hanna, M. D. Sanchez, R. W. Doms & T. C. Pierson: West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol, 80, 1290-301 (2006). (Pubitemid 43134086)
36. Chu, J. J. & M. L. Ng: Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol, 78, 10543-55 (2004). (Pubitemid 39258380)
37. Krishnan, M. N., B. Sukumaran, U. Pal, H. Agaisse, J. L. Murray, T. W. Hodge & E. Fikrig: Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol, 81, 4881-5 (2007). (Pubitemid 46668686)
38. Modis, Y., S. Ogata, D. Clements & S. C. Harrison: Structure of the dengue virus envelope protein after membrane fusion. Nature, 427, 313-9 (2004). (Pubitemid 38133652)
39. Zhang, Y., W. Zhang, S. Ogata, D. Clements, J. H. Strauss, T. S. Baker, R. J. Kuhn & M. G. Rossmann: Conformational changes of the flavivirus E glycoprotein. Structure (Camb), 12, 1607-18 (2004). (Pubitemid 39200514)
40. Allison, S. L., J. Schalich, K. Stiasny, C. W. Mandl, C. Kunz & F. X. Heinz: Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol, 69, 695-700 (1995).
41. Gollins, S. & J. Porterfield: The uncoating and infectivity of the flavivirus West Nile on interaction with cells: effects of pH and ammonium chloride. J.Gen.Virol., 67, 1941-1950 (1986). (Pubitemid 16017278)
42. Mackenzie, J. M. & E. G. Westaway: Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol, 75, 10787-99 (2001). (Pubitemid 33031548)
43. Elshuber, S., S. L. Allison, F. X. Heinz & C. W. Mandl: Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J Gen Virol, 84, 183-91 (2003). (Pubitemid 36113564)
44. Guirakhoo, F., R. A. Bolin & J. T. Roehrig: The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology, 191, 921-31 (1992). (Pubitemid 23022496)
45. Stadler, K., S. L. Allison, J. Schalich & F. X. Heinz: Proteolytic activation of tick-borne encephalitis virus by furin. J Virol, 71, 8475-81 (1997). (Pubitemid 27446428)
46. Camenga, D. L., N. Nathanson & G. A. Cole: Cyclophosphamide- potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis, 130, 634-41 (1974).
47. Glass, W. G., D. H. McDermott, J. K. Lim, S. Lekhong, S. F. Yu, W. A. Frank, J. Pape, R. C. Cheshier & P. M. Murphy: CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med, 203, 35-40 (2006). (Pubitemid 43139642)
48. Diamond, M. S. & R. S. Klein: A genetic basis for human susceptibility to West Nile virus. Trends Microbiol, 14, 287-9 (2006). (Pubitemid 43963363)
49. Lim, J. K., W. G. Glass, D. H. McDermott & P. M. Murphy: CCR5: no longer a "good for nothing" gene- chemokine control of West Nile virus infection. Trends Immunol, 27, 308-12 (2006). (Pubitemid 43963479)
50. Asnis, D. S., R. Conetta, A. A. Teixeira, G. Waldman & B. A. Sampson: The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis, 30, 413-8. (2000). (Pubitemid 30205281)
51. Tsai, T. F., F. Popovici, C. Cernescu, G. L. Campbell & N. I. Nedelcu: West Nile encephalitis epidemic in southeastern Romania. Lancet, 352, 767-71. (1998). (Pubitemid 28404558)
52. Samuel, M. A. & M. S. Diamond: Pathogenesis of West Nile virus infection: A balance between virulence, innate and adaptive immunity, and viral evasion. J Virol, 80, 9349-9360 (2006). (Pubitemid 44435614)
53. Byrne, S. N., G. M. Halliday, L. J. Johnston & N. J. King: Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol, 117, 702-9 (2001). (Pubitemid 32955601)
54. Diamond, M. S., B. Shrestha, A. Marri, D. Mahan & M. Engle: B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol, 77, 2578-2586 (2003). (Pubitemid 36222782)
55. Eldadah, A. H. & N. Nathanson: Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain. Am J Epidemiol, 86, 776-90. (1967).
56. Hunsperger, E. A. & J. T. Roehrig: Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice. J Neurovirol, 12, 129-39 (2006). (Pubitemid 44574603)
57. Shrestha, B., D. I. Gottlieb & M. S. Diamond: Infection and injury of neurons by West Nile Encephalitis virus. J Virol, 77, 13203-13213 (2003). (Pubitemid 37494316)
58. Xiao, S. Y., H. Guzman, H. Zhang, A. P. Travassos da Rosa & R. B. Tesh: West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis, 7, 714-21. (2001). (Pubitemid 32845264)
59. Tesh, R. B., M. Siirin, H. Guzman, A. P. Travassos da Rosa, X. Wu, T. Duan, H. Lei, M. R. Nunes & S. Y. Xiao: Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis, 192, 287-95 (2005). (Pubitemid 40993398)
60. Omalu, B. I., A. A. Shakir, G. Wang, W. I. Lipkin & C. A. Wiley: Fatal fulminant pan-meningopolioencephalitis due to West Nile virus. Brain Pathol, 13, 465-72 (2003). (Pubitemid 37420691)
61. Garcia-Tapia, D., D. E. Hassett, W. J. Mitchell Jr., G. C. Johnson & S. B. Kleiboeker: West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection. J Neurovirol, 13, 130-8 (2007). (Pubitemid 46780088)
62. Shrestha, B. & M. S. Diamond: The role of CD8+ T cells in the control of West Nile virus infection. J Virol, 78, 8312- 8321 (2004). (Pubitemid 38944315)
63. Sitati, E. & M. S. Diamond: CD4+ T Cell responses are required for clearance of West Nile Virus from the central nervous system. J Virol, 80, 12060-12069 (2006). (Pubitemid 44904356)
64. Shrestha, B., M. A. Samuel & M. S. Diamond: CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol, 80, 119-129 (2006).
65. Brenner, W., G. Storch, R. Buller, R. Vij, S. Devine & J. DiPersio: West Nile Virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance. Bone Marrow Transplant, 36, 369-70 (2005). (Pubitemid 41195172)
66. Wang, T., T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig & R. A. Flavell: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med, 10, 1366-73 (2004). (Pubitemid 40022719)
67. Diamond, M. S. & R. S. Klein: West Nile virus: crossing the blood-brain barrier. Nat Med, 10, 1294-1295 (2004). (Pubitemid 40022705)
68. Samuel, M. A. & M. S. Diamond: Type I IFN protects against lethal West Nile Virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol, 79, 13350-13361 (2005). (Pubitemid 41508149)
69. Kramer-Hammerle, S., I. Rothenaigner, H. Wolff, J. E. Bell & R. Brack-Werner: Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res, 111, 194-213 (2005). (Pubitemid 40909736)
70. Monath, T. P., C. B. Cropp & A. K. Harrison: Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest, 48, 399-410 (1983). (Pubitemid 13119063)
71. Garcia-Tapia, D., C. M. Loiacono & S. B. Kleiboeker: Replication of West Nile virus in equine peripheral blood mononuclear cells. Vet Immunol Immunopathol, 110, 229-244 (2005).
72. Rios, M., S. Daniel, C. Chancey, I. K. Hewlett & S. L. Stramer: West Nile virus adheres to human red blood cells in whole blood. Clin Infect Dis, 45, 181-6 (2007). (Pubitemid 47041008)
73. Johnson, R. T.: Viral infections of the nervous system. Raven Press, New York (1982).
74. Hunsperger, E. & J. T. Roehrig: Characterization of West Nile viral replication and maturation in peripheral neurons in culture. J Neurovirol, 11, 11-22 (2005). (Pubitemid 40458367)
75. Samuel, M. A., H. Wang, V. Siddharthan, J. D. Morrey & M. S. Diamond: Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A In press (2007).
76. Klein, R. S., E. Lin, B. Zhang, A. D. Luster, J. Tollett, M. A. Samuel, M. Engle & M. S. Diamond: Neuronal CXCL10 directs CD8+ T cell recruitment and control of West Nile virus encephalitis. J Virol, 79, 11457-11466 (2005). (Pubitemid 41170686)
77. Shirato, K., T. Kimura, T. Mizutani, H. Kariwa & I. Takashima: Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J Med Virol, 74, 507-13 (2004). (Pubitemid 39281652)
78. Platanias, L. C., S. Uddin, P. Domanski & O. R. Colamonici: Differences in Interferon α and β signalling. J.Biol.Chem., 271, 23630-23633 (1996).
79. Ank, N., H. West & S. R. Paludan: IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res, 26, 373-9 (2006).
80. Garcia-Sastre, A. & C. A. Biron: Type 1 interferons and the virus-host relationship: a lesson in detente. Science, 312, 879-82 (2006). (Pubitemid 43727313)
81. Asselin-Paturel, C. & G. Trinchieri: Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med, 202, 461-5 (2005). (Pubitemid 41186943)
82. Le Bon, A. & D. F. Tough: Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol, 14, 432-6 (2002). (Pubitemid 34671244)
83. Le Bon, A., C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, U. Kalinke & D. F. Tough: Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol, 176, 2074-8 (2006). (Pubitemid 43201653)
84. Marrack, P., J. Kappler & T. Mitchell: Type I interferons keep activated T cells alive. J Exp Med, 189, 521-30 (1999).
85. Anderson, J. F. & J. J. Rahal: Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis, 8, 107-8 (2002). (Pubitemid 34094299)
86. Crance, J. M., N. Scaramozzino, A. Jouan & D. Garin: Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res, 58, 73-9 (2003). (Pubitemid 36507224)
87. Evans, J. D. & C. Seeger: Differential Effects of Mutations in NS4B on WNV Replication and Inhibition of Interferon Signaling. J Virol (2007).
88. Keller, B. C., B. L. Fredericksen, M. A. Samuel, R. E. Mock, P. W. Mason, M. S. Diamond & M. Gale Jr.: Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol, 80, 9424-34 (2006). (Pubitemid 44435621)
89. Schroder, K., P. J. Hertzog, T. Ravasi & D. A. Hume: Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol, 75, 163-89 (2004). (Pubitemid 38174573)
90. Chesler, D. A. & C. S. Reiss: The role of IFNgamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev, 13, 441-54 (2002). (Pubitemid 35303815)
91. Shrestha, B., T. Wang, M. A. Samuel, K. Whitby, J. Craft, E. Fikrig & M. S. Diamond: Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol, 80, 5338-48 (2006).
92. Wang, T., E. Scully, Z. Yin, J. H. Kim, S. Wang, J. Yan, M. Mamula, J. F. Anderson, J. Craft & E. Fikrig: IFN-γ-producing γδ T cells help control murine West Nile virus infection. J Immunol, 171, 2524-2531 (2003). (Pubitemid 37025562)
93. Wang, Y., M. Lobigs, E. Lee, A. Koskinen & A. Mullbacher: CD8 (+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon. J Gen Virol, 87, 3599-609 (2006). (Pubitemid 44822017)
94. Getts, D. R., I. Matsumoto, M. Muller, M. T. Getts, J. Radford, B. Shrestha, I. L. Campbell & N. J. King: Role of IFN-gamma in an experimental murine model of West Nile virus-induced seizures. J Neurochem (2007).
95. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira & T. Fujita: The RNA helicase RIG-I has an essential function in double stranded RNA-induced innate antiviral responses. Nat Immunol, 5, 730-737 (2004). (Pubitemid 39023305)
96. Kawai, T. & S. Akira: Innate immune recognition of viral infection. Nat Immunol, 7, 131-7 (2006). (Pubitemid 43135878)
97. Fredericksen, B. L., M. Smith, M. G. Katze, P. Y. Shi & M. Gale: The host response to West Nile virus infection limits spread through the activation of the interferon regulatory factor 3 pathway. J Virol, 78, 7737-7747 (2004). (Pubitemid 38915920)
98. Fredericksen, B. L. & M. Gale Jr.: West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol, 80, 2913-23 (2006). (Pubitemid 43346386)
99. Fredericksen, B. L., B. C. Keller, J. Fornek, M. G. Katze & M. Gale Jr.: Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1 Submitted for publication (2007).
100. Gitlin, L., W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R. A. Flavell, M. S. Diamond & M. Colonna: Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A, 103, 8459-64 (2006). (Pubitemid 43838477)
101. Schroder, M. & A. G. Bowie: TLR3 in antiviral immunity: key player or bystander? Trends Immunol, 26, 462-8 (2005). (Pubitemid 41139255)
102. Matsumoto, M., K. Funami, H. Oshiumi & T. Seya: Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol, 48, 147-54 (2004). (Pubitemid 38405076)
103. Scholle, F. & P. W. Mason: West Nile virus replication interferes with both poly (I:C)-induced interferon gene transcription and response to interferon treatment. Virology, 342, 77-87 (2005). (Pubitemid 41531987)
104. Daffis, S., C. E. Samuel, B. C. Keller, M. Gale Jr. & M. S. Diamond: Toll-like receptor 3 responses in peripheral tissues protect against lethal West Nile virus infection Manuscript submitted (2007).
105. Bourne, N., F. Scholle, M. C. Silva, S. L. Rossi, N. Dewsbury, B. Judy, J. B. De Aguiar, M. A. Leon, D. M. Estes, R. Fayzulin & P. W. Mason: Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J Virol (2007).
106. Daffis, S., M. A. Samuel, B. C. Keller, M. Gale Jr. & M. S. Diamond: Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and independent mechanisms. PLoS Pathog, 3, e106 (2007).
107. Gilfoy, F. D. & P. W. Mason: West Nile virusinduced IFN production is mediated by the double-stranded RNA-dependent protein kinase, PKR. J Virol (2007).
108. Kajaste-Rudnitski, A., T. Mashimo, M. P. Frenkiel, J. L. Guenet, M. Lucas & P. Despres: The 2', 5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J Biol Chem, 281, 4624-37 (2006). (Pubitemid 43847721)
109. Meurs, E. F., Y. Watanabe, S. Kadereit, G. N. Barber, M. G. Katze, K. Chong, B. R. Williams & A. G. Hovanessian: Constitutive expression of human doublestranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol, 66, 5804-14 (1992).
110. Zhou, A., J. Paranjape, T. L. Brown, H. Nie, S. Naik, B. Dong, A. Chang, B. Trapp, R. Fairchild, C. Colmenares & R. H. Silverman: Interferon action and apoptosis are defective in mice devoid of 2', 5'- oligoadenylate-dependent RNase L. Embo J, 16, 6355-63 (1997). (Pubitemid 27483262)
111. Scherbik, S. V., J. M. Paranjape, B. M. Stockman, R. H. Silverman & M. A. Brinton: RNase L plays a role in the antiviral response to West Nile virus. J Virol, 80, 2987-99 (2006). (Pubitemid 43346394)
112. Samuel, M. A., K. Whitby, B. C. Keller, A. Marri, W. Barchet, B. R. G. Williams, R. H. Silverman, M. Gale & M. S. Diamond: PKR and RNAse L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol, 80, 7009-7019 (2006). (Pubitemid 44025199)
113. Perelygin, A. A., S. V. Scherbik, I. B. Zhulin, B. M. Stockman, Y. Li & M. A. Brinton: Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci U S A, 99, 9322-7 (2002). (Pubitemid 34764612)
114. Mashimo, T., M. Lucas, D. Simon-Chazottes, M. P. Frenkiel, X. Montagutelli, P. E. Ceccaldi, V. Deubel, J. L. Guenet & P. Despres: A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A, 99, 11311-6 (2002). (Pubitemid 34920922)
115. Carroll, M. C.: The complement system in regulation of adaptive immunity. Nat Immunol, 5, 981-6 (2004). (Pubitemid 41057714)
116. Mehlhop, E. & M. S. Diamond: Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med, 203, 1371-81 (2006). (Pubitemid 43736604)
117. Mehlhop, E., K. Whitby, T. Oliphant, A. Marri, M. Engle & M. S. Diamond: Complement activation is required for the induction of a protective antibody response against West Nile virus infection. J Virol, 79, 7466-7477 (2005). (Pubitemid 40756783)
118. Cardosa, M. J., J. S. Porterfield & S. Gordon: Complement receptor mediates enhanced flavivirus replication in macrophages. J Exp Med, 158, 258-63 (1983). (Pubitemid 13073528)
119. Cardosa, M. J., S. Gordon, S. Hirsch, T. A. Springer & J. S. Porterfield: Interaction of West Nile virus with primary murine macrophages: role of cell activation and receptors for antibody and complement. J Virol, 57, 952-9 (1986). (Pubitemid 16143977)
120. Iankov, I. D., M. Pandey, M. Harvey, G. E. Griesmann, M. J. Federspiel & S. J. Russell: Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol, 80, 8530-40 (2006). (Pubitemid 44384865)
121. Feng, J. Q., K. Mozdzanowska & W. Gerhard: Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J Virol, 76, 1369-78 (2002). (Pubitemid 34066439)
122. Mozdzanowska, K., J. Feng, M. Eid, D. Zharikova & W. Gerhard: Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components. Virology, 352, 418-26 (2006). (Pubitemid 44216008)
123. Beebe, D. P. & N. R. Cooper: Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol, 126, 1562-8 (1981). (Pubitemid 11149265)
124. Meyer, K., A. Basu, C. T. Przysiecki, L. M. Lagging, A. M. Di Bisceglie, A. J. Conley & R. Ray: Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein. J Virol, 76, 2150-8 (2002). (Pubitemid 34150682)
125. Spruth, M., H. Stoiber, L. Kacani, D. Schonitzer & M. P. Dierich: Neutralization of HIV type 1 by alloimmune sera derived from polytransfused patients. AIDS Res Hum Retroviruses, 15, 533-43 (1999). (Pubitemid 29177849)
126. Aasa-Chapman, M. M., S. Holuigue, K. Aubin, M. Wong, N. A. Jones, D. Cornforth, P. Pellegrino, P. Newton, I. Williams, P. Borrow & A. McKnight: Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J Virol, 79, 2823-30 (2005). (Pubitemid 40270560)
127. Mehlhop, E., C. Ansarah-Sobrinho, S. Johnson, M. Engle, D. H. Fremont, T. C. Pierson & M. S. Diamond: C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection In vitro and In vivo in an IgG Subclass Specific Manner. Cell Host and Microbe, In press (2007).
128. Ben-Nathan, D., I. Huitinga, S. Lustig, N. van Rooijen & D. Kobiler: West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol, 141, 459-69 (1996). (Pubitemid 126706508)
129. Kreil, T. R. & M. M. Eibl: Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology, 219, 304-6 (1996). (Pubitemid 26180409)
130. Lin, Y. L., Y. L. Huang, S. H. Ma, C. T. Yeh, S. Y. Chiou, L. K. Chen & C. L. Liao: Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol, 71, 5227-35 (1997).
131. Johnston, L. J., G. M. Halliday & N. J. King: Phenotypic changes in Langerhans' cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? J Virol, 70, 4761-6. (1996). (Pubitemid 26187470)
132. Steele, C. R., D. E. Oppenheim & A. C. Hayday: Gamma (delta) T cells: non-classical ligands for non-classical cells. Curr Biol, 10, R282-5 (2000). (Pubitemid 30213380)
133. Wang, T., Y. Gao, E. Scully, C. T. Davis, J. F. Anderson, T. Welte, M. Ledizet, R. Koski, J. A. Madri, A. Barrett, Z. Yin, J. Craft & E. Fikrig: Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice. J Immunol, 177, 1825-32 (2006). (Pubitemid 44092520)
134. Vargin, V. V. & B. F. Semenov: Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta Virol, 30, 303-8 (1986). (Pubitemid 16048541)
135. King, N. J. & A. M. Kesson: Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection. J Gen Virol, 69, 2535- 43 (1988).
136. Douglas, M. W., A. M. Kesson & N. J. King: CTL recognition of west Nile virus-infected fibroblasts is cell cycle dependent and is associated with virus-induced increases in class I MHC antigen expression. Immunology, 82, 561-70. (1994). (Pubitemid 24263382)
137. Liu, Y., N. King, A. Kesson, R. V. Blanden & A. Mullbacher: West Nile virus infection modulates the expression of class I and class II MHC antigens on astrocytes in vitro. Ann N Y Acad Sci, 540, 483-5 (1988). (Pubitemid 19115395)
138. King, N. J. & A. M. Kesson: Interaction of flaviviruses with cells of the vertebrate host and decoy of the immune response. Immunol Cell Biol, 81, 207-16 (2003). (Pubitemid 36649267)
139. King, N. J., L. E. Maxwell & A. M. Kesson: Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells. Proc Natl Acad Sci U S A, 86, 911-5 (1989). (Pubitemid 19056261)
140. Diamond, M. S.: Evasion of innate and adaptive immunity by flaviviruses. Immunology and Cell Biology, 81, 196-206 (2003). (Pubitemid 36649266)
141. Chung, K. M., B. S. Thompson, D. H. Fremont & M. S. Diamond: Antibody recognition of cell surfaceassociated NS1 triggers Fc-gamma receptor mediated phagocytosis and clearance of WNV infected cells. J Virol, 81, 9551-5. (2007). (Pubitemid 47311499)
142. Kim, S., K. Iizuka, H. L. Aguila, I. L. Weissman & W. M. Yokoyama: In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A, 97, 2731-6 (2000). (Pubitemid 30159240)
143. Diamond, M. S., E. Sitati, L. Friend, B. Shrestha, S. Higgs & M. Engle: Induced IgM protects against lethal West Nile Virus infection. J Exp Med, 198, 1-11 (2003).
144. Oliphant, T., M. Engle, G. Nybakken, C. Doane, S. Johnson, L. Huang, S. Gorlatov, E. Mehlhop, A. Marri, K. M. Chung, G. D. Ebel, L. D. Kramer, D. H. Fremont & M. S. Diamond: Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nature Medicine, 11, 522-530 (2005). (Pubitemid 40685975)
145. Oliphant, T., G. Nybakken, M. Engle, Q. Xu, C. A. Nelson, S. Sukupolvi-Petty, A. Marri, B. Lachmi, U. Olshevsky, D. H. Fremont, T. C. Pierson & M. S. Diamond: Determinants of West Nile Virus Envelope Protein Domains I and II Antibody Recognition and Neutralization. J Virol, 80, 12149-12159 (2006). (Pubitemid 44904366)
146. Wang, T., J. F. Anderson, L. A. Magnarelli, S. J. Wong, R. A. Koski & E. Fikrig: Immunization of mice against West Nile virus with recombinant envelope protein. J Immunol, 167, 5273-7. (2001). (Pubitemid 33009765)
147. Gould, L. H., J. Sui, H. Foellmer, T. Oliphant, T. Wang, M. Ledizet, A. Murakami, K. Noonan, C. Lambeth, K. Kar, J. F. Anderson, A. M. de Silva, M. S. Diamond, R. A. Koski, W. A. Marasco & E. Fikrig: Protective and therapeutic capacity of human single chain Fv-Fc fusion proteins against West Nile virus. J Virol, 79, 14606-14613 (2005). (Pubitemid 41636259)
148. Throsby, M., C. Geuijen, J. Goudsmit, A. Q. Bakker, J. Korimbocus, R. A. Kramer, M. Clijsters-van der Horst, M. de Jong, M. Jongeneelen, S. Thijsse, R. Smit, T. J. Visser, N. Bijl, W. E. Marissen, M. Loeb, D. J. Kelvin, W. Preiser, J. ter Meulen & J. de Kruif: Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J Virol, 80, 6982-92 (2006). (Pubitemid 44025197)
149. Engle, M. & M. S. Diamond: Antibody prophylaxis and therapy against West Nile Virus infection in wild type and immunodeficient mice. J Virol, 77, 12941-12949 (2003). (Pubitemid 37494289)
150. Ben-Nathan, D., S. Lustig, G. Tam, S. Robinzon, S. Segal & B. Rager-Zisman: Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating west nile virus infection in mice. J Infect Dis, 188, 5-12 (2003). (Pubitemid 36829736)
151. Tesh, R. B., J. Arroyo, A. P. Travassos Da Rosa, H. Guzman, S. Y. Xiao & T. P. Monath: Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg Infect Dis, 8, 1392-7 (2002). (Pubitemid 36008774)
152. Oliphant, T., G. E. Nybakken, S. K. Austin, Q. Xu, J. Bramson, M. Loeb, M. Throsby, D. H. Fremont, T. C. Pierson & M. S. Diamond: The Induction of Epitope- Specific Neutralizing Antibodies against West Nile virus. J Virol, 81, 11828-39 (2007). (Pubitemid 47623815)
153. Roehrig, J. T., L. A. Staudinger, A. R. Hunt, J. H. Mathews & C. D. Blair: Antibody prophylaxis and therapy for flaviviral encephalitis infections. Ann NY Acad Sci 286- 297 (2001). (Pubitemid 34060052)
154. Churdboonchart, V., N. Bhamarapravati, S. Peampramprecha & S. Sirinavin: Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg, 44, 481-93 (1991).
155. Vazquez, S., M. G. Guzman, G. Guillen, G. Chinea, A. B. Perez, M. Pupo, R. Rodriguez, O. Reyes, H. E. Garay, I. Delgado, G. Garcia & M. Alvarez: Immune response to synthetic peptides of dengue prM protein. Vaccine, 20, 1823-30 (2002). (Pubitemid 34242839)
156. Chung, K. M., G. E. Nybakken, B. S. Thompson, M. J. Engle, A. Marri, D. H. Fremont & M. S. Diamond: Antibodies against West Nile virus non-structural (NS)-1 protein prevent lethal infection through Fc gamma receptor-dependent and independent mechanisms. J Virol, 80, 1340-1351 (2006). (Pubitemid 43134091)
157. Valdes, K., M. Alvarez, M. Pupo, S. Vazquez, R. Rodriguez & M. G. Guzman: Human Dengue antibodies against structural and nonstructural proteins. Clin Diagn Lab Immunol, 7, 856-7 (2000).
158. Wong, S. J., R. H. Boyle, V. L. Demarest, A. N. Woodmansee, L. D. Kramer, H. Li, M. Drebot, R. A. Koski, E. Fikrig, D. A. Martin & P. Y. Shi: Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol, 41, 4217-23 (2003). (Pubitemid 37099687)
159. Nybakken, G. E., C. A. Nelson, B. R. Chen, M. S. Diamond & D. H. Fremont: Crystal structure of the West Nile virus envelope glycoprotein. J Virol, 80, 11467-11474 (2006). (Pubitemid 44788862)
160. Kanai, R., K. Kar, K. Anthony, L. H. Gould, M. Ledizet, E. Fikrig, W. A. Marasco, R. A. Koski & Y. Modis: Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol, 80, 11000-8 (2006). (Pubitemid 44706541)
161. Nybakken, G., T. Oliphant, S. Johnson, S. Burke, M. S. Diamond & D. H. Fremont: Structural basis for neutralization of a therapeutic antibody against West Nile virus. Nature, 437, 764-769 (2005). (Pubitemid 41486548)
162. Beasley, D. W. & A. D. Barrett: Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol, 76, 13097-13100 (2002). (Pubitemid 35386997)
163. Volk, D. E., D. W. Beasley, D. A. Kallick, M. R. Holbrook, A. D. Barrett & D. G. Gorenstein: Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem, 279, 38755-38761 (2004). (Pubitemid 39296033)
164. Rey, F. A., F. X. Heinz, C. Mandl, C. Kunz & S. C. Harrison: The envelope glycoprotein from tick-borne encephalitis virus at 2 Angstrom resolution. Nature, 375, 291-8 (1995).
165. Allison, S. L., J. Schalich, K. Stiasny, C. W. Mandl & F. X. Heinz: Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol, 75, 4268- 75 (2001). (Pubitemid 32410139)
166. Bressanelli, S., K. Stiasny, S. L. Allison, E. A. Stura, S. Duquerroy, J. Lescar, F. X. Heinz & F. A. Rey: Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. Embo J, 23, 728-38 (2004). (Pubitemid 38425440)
167. Bhardwaj, S., M. Holbrook, R. E. Shope, A. D. Barrett & S. J. Watowich: Biophysical characterization and vector-specific antagonist activity of domain III of the tickborne flavivirus envelope protein. J Virol, 75, 4002-7 (2001). (Pubitemid 32246412)
168. Chu, J. J., R. Rajamanonmani, J. Li, R. Bhuvanakantham, J. Lescar & M. L. Ng: Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol, 86, 405-12 (2005). (Pubitemid 40227952)
169. Beasley, D. W., M. C. Whiteman, S. Zhang, C. Y. Huang, B. S. Schneider, D. R. Smith, G. D. Gromowski, S. Higgs, R. M. Kinney & A. D. Barrett: Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol, 79, 8339-47 (2005). (Pubitemid 40853537)
170. Shirato, K., H. Miyoshi, A. Goto, Y. Ako, T. Ueki, H. Kariwa & I. Takashima: Viral envelope protein glycosylation is a molecular determinant of the nueroinvasiveness of the New York strain of Wesr Nile virus. J Gen Virol, 85, 3637-3645 (2004). (Pubitemid 39591870)
171. Hanna, S. L., T. C. Pierson, M. D. Sanchez, A. A. Ahmed, M. M. Murtadha & R. W. Doms: N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J Virol, 79, 13262-74 (2005). (Pubitemid 41508141)
172. Davis, C. W., L. M. Mattei, H. Y. Nguyen, R. W. Doms & T. C. Pierson: The location of N-linked glycans on West Nile virions controls their interactions with CD209. J Biol Chem, 281, 37183-37194 (2006).
173. Mondotte, J. A., P. Y. Lozach, A. Amara & A. V. Gamarnik: Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation. J Virol, 81, 7136-48 (2007). (Pubitemid 46986649)
174. Zhang, W., P. R. Chipman, J. Corver, P. R. Johnson, Y. Zhang, S. Mukhopadhyay, T. S. Baker, J. H. Strauss, M. G. Rossmann & R. J. Kuhn: Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol, 10, 907-912 (2003). (Pubitemid 37386099)
175. Zhang, Y., J. Corver, P. R. Chipman, W. Zhang, S. V. Pletnev, D. Sedlak, T. S. Baker, J. H. Strauss, R. J. Kuhn & M. G. Rossmann: Structures of immature flavivirus particles. Embo J, 22, 2604-13 (2003). (Pubitemid 36712358)
176. Roehrig, J. T., A. J. Johnson, A. R. Hunt, R. A. Bolin & M. C. Chu: Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology, 177, 668-75 (1990). (Pubitemid 20235188)
177. Heinz, F., K. Stiasny, G. Puschner-Auer, H. Holzmann, S. Allison, C. Mandl & C. Kunz: Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with the protein prM. Virology, 198, 109-117 (1994).
178. Heinz, F., G. Auer, K. Stiasny, H. Holzmann, C. Mandl, F. Guirakhoo & C. Kunz: The interactions of the flavivirus envelope proteins: implications for virus entry and release. Arch.Virol., 9 (S), 339-348 (1994).
179. Wengler, G.: Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol, 63, 2521-6 (1989). (Pubitemid 19137526)
180. Mukhopadhyay, S., B. S. Kim, P. R. Chipman, M. G. Rossmann & R. J. Kuhn: Structure of West Nile virus. Science, 302, 248 (2003). (Pubitemid 37248748)
181. Kuhn, R. J., W. Zhang, M. G. Rossmann, S. V. Pletnev, J. Corver, E. Lenches, C. T. Jones, S. Mukhopadhyay, P. R. Chipman, E. G. Strauss, T. S. Baker & J. H. Strauss: Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell, 108, 717-25 (2002). (Pubitemid 34241430)
182. Kauffman, B., G. Nybakken, P. R. Chipman, W. Zhang, D. H. Fremont, M. S. Diamond, R. J. Kuhn & M. G. Rossmann: West Nile virus in complex with a neutralizing monoclonal antibody. Proc Natl Acad Sci U S A, 103, 12400-12404 (2006). (Pubitemid 44267271)
183. Pierson, T. C., Q. Xu, S. Nelson, T. Oliphant, G. E. Nybakken, D. H. Fremont & M. S. Diamond: The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host and Microbe, 1, 135-145 (2007). (Pubitemid 46554914)
184. Heinz, F. X., R. Berger, W. Tuma & C. Kunz: A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology, 126, 525-37 (1983). (Pubitemid 13089876)
185. Roehrig, J. T., R. A. Bolin & R. G. Kelly: Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology, 246, 317-28 (1998). (Pubitemid 28384045)
186. Kimura-Kuroda, J. & K. Yasui: Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies. J Virol, 45, 124-32 (1983). (Pubitemid 13166286)
187. Lin, B., C. R. Parrish, J. M. Murray & P. J. Wright: Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology, 202, 885-90 (1994).
188. Mason, P. W., J. M. Dalrymple, M. K. Gentry, J. M. McCown, C. H. Hoke, D. S. Burke, M. J. Fournier & T. L. Mason: Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol, 70 ( Pt 8), 2037-49 (1989). (Pubitemid 19215108)
189. Sukupolvi-Petty, S., W. E. Purtha, S. K. Austin, T. Oliphant, G. Nybakken, J. J. Schlesinger, J. T. Roehrig, G. D. Gromowski, A. D. Barrett, D. H. Fremont & M. S. Diamond: Type- and Sub-Complex-Specific Neutralizing Antibodies Against Domain III of Dengue Virus Type-2 Envelope Protein Recognize Adjacent Epitopes. J Virol, 81, 12816-26 (2007). (Pubitemid 350156919)
190. Gromowski, G. D. & A. D. Barrett: Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology, 366, 349-60 (2007). (Pubitemid 47398915)
191. Megret, F., J. P. Hugnot, A. Falconar, M. K. Gentry, D. M. Morens, J. M. Murray, J. J. Schlesinger, P. J. Wright, P. Young, M. H. Van Regenmortel & et al.: Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology, 187, 480-91 (1992).
192. Guirakhoo, F., F. X. Heinz & C. Kunz: Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH. Virology, 169, 90-9 (1989). (Pubitemid 19080151)
193. Beasley, D. W. & J. G. Aaskov: Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies. Virology, 279, 447-58 (2001). (Pubitemid 34161109)
194. Cecilia, D. & E. A. Gould: Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology, 181, 70-7 (1991).
195. Choi, K. S., J. J. Nah, Y. J. Ko, Y. J. Kim & Y. S. Joo: The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization. Virus Res, 123, 216-8 (2006).
196. Sanchez, M. D., T. C. Pierson, D. McAllister, S. L. Hanna, B. A. Puffer, L. E. Valentine, M. M. Murtadha, J. A. Hoxie & R. W. Doms: Characterization of neutralizing antibodies to West Nile virus. Virology, 336, 70-82 (2005). (Pubitemid 40603672)
197. Wu, K. P., C. W. Wu, Y. P. Tsao, T. W. Kuo, Y. C. Lou, C. W. Lin, S. C. Wu & J. W. Cheng: Structural basis of a Flavivirus recognized by its neutralizing antibody: Solution structure of the domain III of the Japanese Encephalitis virus envelope protein. J Biol Chem 278, 46007-13 (2003).
198. Crill, W. D. & G. J. Chang: Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol, 78, 13975-86 (2004). (Pubitemid 39612794)
199. Stiasny, K., S. Kiermayr, H. Holzmann & F. X. Heinz: Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol, 80, 9557-68 (2006). (Pubitemid 44435631)
200. Wang, Y., M. Lobigs, E. Lee & A. Mullbacher: CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol, 77, 13323-34 (2003). (Pubitemid 37494327)
201. Purtha, W. E., N. Myers, V. Mitaksov, E. Sitati, J. Connolly, D. H. Fremont, T. H. Hansen & M. S. Diamond: Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol, 37, 1845-54(2007). (Pubitemid 47065123)
202. Brien, J. D., J. L. Uhrlaub & J. Nikolich-Zugich: Protective capacity and epitope specificity of CD8 (+) T cells responding to lethal West Nile virus infection. Eur J Immunol, 37, 1855-1863 (2007). (Pubitemid 47065124)
203. Murray, K., S. Baraniuk, M. Resnick, R. Arafat, C. Kilborn, K. Cain, R. Shallenberger, T. L. York, D. Martinez, J. S. Hellums, D. Hellums, M. Malkoff, N. Elgawley, W. McNeely, S. A. Khuwaja & R. B. Tesh: Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect, 134, 1325-32 (2006). (Pubitemid 44614956)
204. Pruitt, A. A.: Central nervous system infections in cancer patients. Semin Neurol, 24, 435-52 (2004). (Pubitemid 40076120)
205. Kulkarni, A. B., A. Mullbacher & R. V. Blanden: In vitro T-cell proliferative response to the flavivirus, west Nile. Viral Immunol, 4, 73-82. (1991).
206. Kesson, A. M., R. V. Blanden & A. Mullbacher: The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile. J Gen Virol, 68, 2001-6. (1987). (Pubitemid 17120450)
207. Wang, Y., M. Lobigs, E. Lee & A. Mullbacher: Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice. Immunol Cell Biol, 82, 170-3 (2004). (Pubitemid 38594648)
208. Shrestha, B. & M. S. Diamond: Fas ligand interactions contribute to CD8+ T cell-mediated control of West Nile virus infection in the central nervous system. J Virol, 81, 11749-57 (2007). (Pubitemid 47623807)
209. Ransohoff, R. M.: The chemokine system in neuroinflammation: an update. J Infect Dis, 186 Suppl 2, S152-6 (2002). (Pubitemid 35370475)
210. Asensio, V. C. & I. L. Campbell: Chemokines and viral diseases of the central nervous system. Adv Virus Res, 56, 127-73 (2001). (Pubitemid 33804560)
211. Glass, W. G., J. K. Lim, R. Cholera, A. G. Pletnev, J. L. Gao & P. M. Murphy: Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med, 202, 1087-98 (2005). (Pubitemid 41464502)
212. Sitati, E., E. E. McCandless, R. S. Klein & M. S. Diamond: CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis. J Virol, 81, 9801- 9811 (2007). (Pubitemid 350067684)
213. Chu, J. J. & M. L. Ng: The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J Gen Virol, 84, 3305-14 (2003). (Pubitemid 37540758)
214. Parquet, M. C., A. Kumatori, F. Hasebe, K. Morita & A. Igarashi: West Nile virus-induced bax-dependent apoptosis. FEBS Lett, 500, 17-24 (2001). (Pubitemid 32575311)
215. Samuel, M. A., J. D. Morrey & M. S. Diamond: Caspase-3 dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J Virol, 81, 2614-2623 (2007). (Pubitemid 46447027)
216. Liao, C. L., Y. L. Lin, J. J. Wang, Y. L. Huang, C. T. Yeh, S. H. Ma & L. K. Chen: Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells. J Virol, 71, 5963-71. (1997).
217. Parquet, M. C., A. Kumatori, F. Hasebe, E. G. Mathenge & K. Morita: St. Louis encephalitis virus induced pathology in cultured cells. Arch Virol, 147, 1105- 19 (2002). (Pubitemid 34592881)
218. Ramanathan, M. P., J. A. Chambers, P. Pankhong, M. Chattergoon, W. Attatippaholkun, K. Dang, N. Shah & D. B. Weiner: Host cell killing by the West Nile Virus NS2BNS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology, 345, 56-72 (2006). (Pubitemid 43107573)
219. Yang, J. S., M. P. Ramanathan, K. Muthumani, A. Y. Choo, S. H. Jin, Q. C. Yu, D. S. Hwang, D. K. Choo, M. D. Lee, K. Dang, W. Tang & J. J. Kim: Induction of Inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerg Infect Dis, 8, 1379-84 (2002). (Pubitemid 36008772)
220. Koh, W. L. & M. L. Ng: Molecular mechanisms of West Nile virus pathogenesis in brain cell. Emerg Infect Dis, 11, 629-32 (2005).
221. Venter, M., T. G. Myers, M. A. Wilson, T. J. Kindt, J. T. Paweska, F. J. Burt, P. A. Leman & R. Swanepoel: Gene expression in mice infected with West Nile virus strains of different neurovirulence. Virology, 342, 119-40 (2005). (Pubitemid 41531991)
222. Sumbayev, V. V. & I. M. Yasinska: Role of MAP kinase-dependent apoptotic pathway in innate immune responses and viral infection. Scand J Immunol, 63, 391- 400 (2006). (Pubitemid 43978854)
223. Kleinschmidt, M. C., M. Michaelis, H. Ogbomo, H. W. Doerr & J. Cinatl Jr.: Inhibition of apoptosis prevents West Nile virus induced cell death. BMC Microbiol, 7, 49 (2007).
224. Medigeshi, G. R., A. M. Lancaster, A. J. Hirsch, T. Briese, W. I. Lipkin, V. Defilippis, K. Fruh, P. W. Mason, J. Nikolich-Zugich & J. A. Nelson: West Nile virus infection activates the unfolded protein response leading to CHOP induction and apoptosis. J Virol, 81:10849-60 (2007). (Pubitemid 47536059)